Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (471-480 of 726) with videos related to

Pageof 73
Sort By:
Journal of Surgical Oncology|January 1, 1981
Combination therapy for advanced malignant melanoma with BCNU, pseudomonas vaccine, and heparinR D Snyder, G N Hortobagyi, G P Bodey, et al.
Chemotherapy|September 1, 1996
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer centerK V Rolston, L Elting, S Waguespack, et al.
The New England Journal of Medicine|November 1, 1971
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemiaE M Hersh, J P Whitecar, K B McCredie, et al.
Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.
Cancer Treatment Reports|October 1, 1978
Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracilA Y Bedikian, R Staab, R Livingston, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Significance of aspergillemia in patients with cancer: a 10-year studyD P Kontoyiannis, D Sumoza, J Tarrand, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 18, 2004
The significance of blood cultures positive for emerging saprophytic moulds in cancer patientsM S Lionakis, G P Bodey, J J Tarrand, et al.
The American Journal of the Medical Sciences|January 1, 1984
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignanciesR D Lawson, L O Gentry, G P Bodey, et al.
Investigational New Drugs|December 1, 1988
Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)]S P Chawla, B S Yap, D M Tenney, et al.
Pageof 73

Showing results (471-480 of 726) with videos related to

Sort By:
Pageof 73
Journal of Surgical Oncology|January 1, 1981
Combination therapy for advanced malignant melanoma with BCNU, pseudomonas vaccine, and heparinR D Snyder, G N Hortobagyi, G P Bodey, et al.
Chemotherapy|September 1, 1996
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer centerK V Rolston, L Elting, S Waguespack, et al.
The New England Journal of Medicine|November 1, 1971
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemiaE M Hersh, J P Whitecar, K B McCredie, et al.
Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.
Cancer Treatment Reports|October 1, 1978
Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracilA Y Bedikian, R Staab, R Livingston, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Significance of aspergillemia in patients with cancer: a 10-year studyD P Kontoyiannis, D Sumoza, J Tarrand, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 18, 2004
The significance of blood cultures positive for emerging saprophytic moulds in cancer patientsM S Lionakis, G P Bodey, J J Tarrand, et al.
The American Journal of the Medical Sciences|January 1, 1984
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignanciesR D Lawson, L O Gentry, G P Bodey, et al.
Investigational New Drugs|December 1, 1988
Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)]S P Chawla, B S Yap, D M Tenney, et al.
Pageof 73